Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Invasive Fungal Infections 2Pulmonary Aspergillosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Mycoses 1Leukemia, Myelomonocytic, Acute 1Leukemia 1Invasive Pulmonary Aspergillosis 1Hematologic Neoplasms 1Aspergillosis 1

Interventions

Cytarabine 26Daunorubicin 11Mitoxantrone 7Idarubicin 7Etoposide 7fludarabine phosphate 6Filgrastim 6Busulfan 6Tacrolimus 5Peripheral Blood Stem Cell Transplantation 5Methotrexate 5Gemtuzumab 5Clofarabine 5tipifarnib 4alvocidib 4Vorinostat 4Decitabine 4Azacitidine 4sargramostim 3Whole-Body Irradiation 3Observation 3Mycophenolic Acid 3Granulocyte Colony-Stimulating Factor 3Bortezomib 3Biopsy 3Antilymphocyte Serum 3entinostat 2Sirolimus 2Pravastatin 2Flow Cytometry 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Myelomonocytic, Acute × Amphotericin B × Clear all
NCT01615809 2018-03-29

Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia

Fundació Sant Joan de Déu

Phase 2 Completed
32 enrolled 6 charts
LymphoidOther hematologic neoplasm

Invasive Fungal Infections, Aspergillosis, Leukemia, Mycoses, Leukemia, Myelomonocytic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Pulmonary Aspergillosis, Invasive Pulmonary Aspergillosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡